Filing Details

Accession Number:
0001415889-20-003035
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 18:01:14
Reporting Period:
2020-12-22
Accepted Time:
2020-12-28 18:01:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
201 Industrial Road Suite 410
San Carlos CA 94070
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-22 1,077 $0.00 68,169 No 4 M Direct
Common Stock Disposition 2020-12-23 427 $110.83 67,742 No 4 S Direct
Common Stock Acquisiton 2020-12-24 6,694 $10.41 74,436 No 4 M Direct
Common Stock Acquisiton 2020-12-24 33,228 $9.29 107,664 No 4 M Direct
Common Stock Acquisiton 2020-12-24 20,833 $19.68 128,497 No 4 M Direct
Common Stock Disposition 2020-12-24 25,773 $109.27 102,724 No 4 S Direct
Common Stock Disposition 2020-12-24 16,779 $110.17 85,945 No 4 S Direct
Common Stock Disposition 2020-12-24 24,348 $111.23 61,597 No 4 S Direct
Common Stock Disposition 2020-12-24 11,014 $112.01 50,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-12-22 1,077 $0.00 1,077 $0.00
Common Stock Stock Option (right to buy) Disposition 2020-12-24 6,694 $0.00 6,694 $10.41
Common Stock Stock Option (right to buy) Disposition 2020-12-24 33,228 $0.00 33,228 $9.29
Common Stock Stock Option (right to buy) Disposition 2020-12-24 20,833 $0.00 20,833 $19.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,696 No 4 M Direct
10,564 2027-06-08 No 4 M Direct
15,105 2028-03-08 No 4 M Direct
29,167 2029-03-21 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 22, 2020.
  2. Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs.
  4. The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2020.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.70 to $109.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.70 to $110.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110,71 to $111.68 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.72 to $112.36 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The RSUs vest over four years. 25% of the RSUs vested on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
  10. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
  11. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
  12. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.